Publication: Microengineered biosynthesized cellulose as anti-fibrotic in vivo protection for cardiac implantable electronic devices
Microengineered biosynthesized cellulose as anti-fibrotic in vivo protection for cardiac implantable electronic devices
Date
Date
Date
Citations
Robotti, F., Sterner, I., Bottan, S., Monné Rodríguez, J. M., Pellegrini, G., Schmidt, T., Falk, V., Poulikakos, D., Ferrari, A., & Starck, C. (2020). Microengineered biosynthesized cellulose as anti-fibrotic in vivo protection for cardiac implantable electronic devices. Biomaterials, 229, 119583. https://doi.org/10.1016/j.biomaterials.2019.119583
Abstract
Abstract
Abstract
Upon cardiac implantable electronic device (CIED) exchange, upgrade, or revision surgery patients are exposed to a considerable risk of adverse events. The presence of firm fibrotic tissue endangers these procedures. Leads can be damaged in the attempt of freeing them from fibrotic tissue. Hematoma can form as result of capsulectomy, pocket debridement and leads dissection. Due to the increasing number of CIED exchange, upgrade and revision surgeries, the incidence of related complications is expected to rise in the near future.The ai
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Page Range
Page Range
Page Range
Item Type
Item Type
Item Type
In collections
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Publisher DOI
Metrics
Downloads
Views
Citations
Robotti, F., Sterner, I., Bottan, S., Monné Rodríguez, J. M., Pellegrini, G., Schmidt, T., Falk, V., Poulikakos, D., Ferrari, A., & Starck, C. (2020). Microengineered biosynthesized cellulose as anti-fibrotic in vivo protection for cardiac implantable electronic devices. Biomaterials, 229, 119583. https://doi.org/10.1016/j.biomaterials.2019.119583